Fresenius SE & Co KGaA (FRE) Given a €80.00 Price Target by Warburg Research Analysts

Fresenius SE & Co KGaA (FRA:FRE) received a €80.00 ($98.77) price objective from Warburg Research in a research report issued on Thursday. The brokerage currently has a “buy” rating on the stock. Warburg Research’s price objective would suggest a potential upside of 27.23% from the stock’s previous close.

Several other analysts have also recently issued reports on the company. Commerzbank set a €85.00 ($104.94) target price on Fresenius SE & Co KGaA and gave the company a “buy” rating in a research report on Monday, November 6th. Kepler Capital Markets set a €63.00 ($77.78) target price on Fresenius SE & Co KGaA and gave the stock a “neutral” rating in a research note on Tuesday, November 28th. HSBC set a €70.00 ($86.42) price objective on Fresenius SE & Co KGaA and gave the company a “neutral” rating in a research note on Wednesday, November 22nd. Deutsche Bank set a €83.00 ($102.47) price objective on Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Friday, December 1st. Finally, Bank of America set a €75.00 ($92.59) price objective on Fresenius SE & Co KGaA and gave the company a “neutral” rating in a research note on Monday, November 6th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of €78.80 ($97.28).

Shares of Fresenius SE & Co KGaA (FRE) traded down €2.12 ($2.62) during midday trading on Thursday, reaching €62.88 ($77.63). The company’s stock had a trading volume of 1,569,683 shares. The company has a market cap of $35,750.00 and a PE ratio of 20.03. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($74.27) and a 1-year high of €80.00 ($98.77).

TRADEMARK VIOLATION WARNING: “Fresenius SE & Co KGaA (FRE) Given a €80.00 Price Target by Warburg Research Analysts” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/02/08/fresenius-se-80-00-price-target-by-warburg-research-analysts.html.

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply